Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Randolph E Patterson, Emory University
ClinicalTrials.gov Identifier:
NCT00166179
First received: September 13, 2005
Last updated: September 25, 2014
Last verified: September 2014
  Purpose

The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.


Condition
Coronary Artery Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

Resource links provided by NLM:


Further study details as provided by Emory University:

Primary Outcome Measures:
  • Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI [ Time Frame: time of initial scans ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Compare size of regions of viable and non viable myocardium as % left ventricle by MRI vs. PET [ Time Frame: at time of initial scans ] [ Designated as safety issue: No ]

Enrollment: 57
Study Start Date: November 2003
Study Completion Date: October 2006
Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Age > 25 yrs, mean + SD = 60.3 + 10.2, 83% male, are patients referred by cardiologist or cardiac surgeon for assessment of myocardial viability by PET FDG.

Criteria

Inclusion Criteria:

  • PET-FDG ordered to assess myocardial viability

Exclusion Criteria:

  • Contraindicated for MRI
  • Pregnant
  • Age <25 yrs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00166179

Locations
United States, Georgia
Crawford Long Hospital
Atlanta, Georgia, United States, 30308
Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: Randolph Patterson, MD Staff
  More Information

No publications provided

Responsible Party: Randolph E Patterson, Professor, Emory University
ClinicalTrials.gov Identifier: NCT00166179     History of Changes
Other Study ID Numbers: IRB00000292, 6-56550
Study First Received: September 13, 2005
Last Updated: September 25, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Emory University:
CAD

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on October 01, 2014